McKesson Ventures
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Samsung Electronics Acquires Xealth, Bridging The Gap Between Wellness and Medical Care

by McKesson Ventures | Jul 11, 2025 | Press Releases

We’re excited to share that on Tuesday, July 8th, digital healthcare integration provider and McKesson Ventures portfolio company Xealth announced that it had been acquired by Samsung Electronics Co, Ltd. The acquisition seeks to combine Samsung’s innovative wearable...

Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada

by McKesson Ventures | Apr 28, 2025 | Press Releases

On Monday, April 28th, clinical real-world data (RWD) company Atropos Health announced that it would be collaborating with community oncology real-world data (RWD) provider Ontada to enhance oncology data use cases for clinicians, researchers, and healthcare leaders —...

Merck Announces the Launch of the Merck Digital Sciences Studio to Help Healthcare Startups Quickly Bring their Innovations to Market

by McKesson Ventures | Jun 29, 2022 | Media Coverage, Press Releases

Merck, known as MSD outside the U.S. and Canada, has announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development. MDSS will support early-stage biomedical startups with direct...

McKesson Ventures Takes the ParityPledge to Commit to Increasing Representation for Women and People of Color

by McKesson Ventures | Jun 17, 2022 | Press Releases

McKesson Ventures has signed the Parity.org ParityPledge® in Support of People of Color and in Support of Women. The ParityPledge simply asks that companies commit to interview and consider at least one qualified woman and person of color for every open role, VP and...

Koneksa Raises $45M Series C Financing to Accelerate Expansion of Digital Biomarker Platform

by McKesson Ventures | Feb 7, 2022 | Press Releases

Digital biomarker design and validation company Koneksa recently announced that it had completed a Series C funding round in which it raised $45 million. The funding round was led by AyurMaya, with Velosity Capital and Takeda Ventures participating as well. Existing...
Page 1 of 1012345...10...»Last »

Recent Posts

  • Samsung Electronics Acquires Xealth, Bridging The Gap Between Wellness and Medical Care
  • CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuth
  • Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry
  • Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada
  • Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care
McKesson Ventures
One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us

Cookie Settings

In the News

Samsung Electronics Acquires Xealth, Bridging The Gap Between Wellness and Medical Care

CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuth

Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry

Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada

©2025 McKesson Ventures | Privacy Notice | Disclaimer
  • Follow
  • Follow